source
- Biogen makes up to $1B deal for secretive anti-inflammatory biotechBiogen will pay as much as $1 billion — “predominantly” in milestone payments — to acquire a San Diego biotech that has disclosed little about its pipeline. The startup, RayThera, debuted last year…Endpoints · 1mo ago↗ source
- FDA gives rejected drugs another chance in post-Makary eraDid you receive a complete response letter in the past year? Now may be the time for a resubmission. In the wake of FDA Commissioner Marty Makary's departure last month, the agency has already agre…Endpoints · 1mo ago↗ source
- FDA warns telehealth companies over compounded GLP-1sThe FDA has issued a new batch of warning letters to 25 telehealth companies, accusing them of making false and misleading claims in their marketing of compounded GLP-1 weight loss drugs. The lette…